# EDGAR Filing Document

**Accession Number:** 0001671927
**File Stem:** 0001140361-23-011038
**Filing Date:** 2023-3
**Character Count:** 3291
**Document Hash:** b0b1a6d3eeb8af253cb75faafd3b390c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-23-011038.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001140361-23-011038

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230310

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Immunocore Holdings plc
- **CENTRAL INDEX KEY:** 0001671927
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39992
- **FILM NUMBER:** 23721566

**BUSINESS ADDRESS:**
- **STREET 1:** 90 PARK DRIVE
- **STREET 2:** MILTON PARK, ABINGDON
- **CITY:** OXFORDSHIRE
- **STATE:** X0
- **ZIP:** OX14 4RY
- **BUSINESS PHONE:** 01235 5430281

**MAIL ADDRESS:**
- **STREET 1:** 90 PARK DRIVE
- **STREET 2:** MILTON PARK, ABINGDON
- **CITY:** OXFORDSHIRE
- **STATE:** X0
- **ZIP:** OX14 4RY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Immunocore Ltd
- **DATE OF NAME CHANGE:** 20160412

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### FORM 6-K

------

#### REPORT OF FOREIGN PRIVATE ISSUER

#### PURSUANT TO RULE 13a-16 OR 15d-16

#### UNDER THE SECURITIES EXCHANGE ACT OF 1934

#### For the Month of March 2023

#### Commission File Number: 001-39992

------

## Immunocore Holdings plc

#### (Translation of registrant's name into English)

------

#### 92 Park Drive

#### Milton Park

#### Abingdon, Oxfordshire OX14 4RY

#### United Kingdom

#### (Address of principal executive office)

------

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

#### INCORPORATION BY REFERENCE

The information in this Report on Form 6-K (this "Report") of Immunocore Holdings plc (the "Company") is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

#### INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

#### Announcement
The Company informs its investors that it does not hold cash deposits or securities at Silicon Valley Bank.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **IMMUNOCORE HOLDINGS PLC** | **IMMUNOCORE HOLDINGS PLC** | **IMMUNOCORE HOLDINGS PLC** |
| Date: March 10, 2023 | By: | /s/ Bahija Jallal, Ph.D. | /s/ Bahija Jallal, Ph.D. |
|  |  | Name: | Bahija Jallal, Ph.D. |
|  |  | Title: | Chief Executive Officer |

---

------